Century Therapeutics Inc. (IPSC)

0.61

-0.07 (-10.66%)

At close: Mar 03, 2025, 3:59 PM

0.64

4.88%

After-hours: Mar 03, 2025, 04:44 PM EST

Century Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-136.67M	-130.93M	-95.82M	-53.58M	-244.77M
Depreciation & Amortization	13.04M	8.44M	3.75M	1.4M	249K
Stock-Based Compensation	14.62M	10.67M	4.66M	876K	147K
Other Working Capital	11.74M	128.73M	-949K	2.8M	1.03M
Other Non-Cash Items	11.28M	1.93M	1.21M	444K	225.95M
Deferred Income Tax	n/a	n/a	n/a	4.72M	n/a
Change in Working Capital	9.38M	123.94M	-2.8M	4.86M	2.26M
Operating Cash Flow	-88.35M	14.05M	-89M	-41.27M	-16.17M
Capital Expenditures	-13.74M	-30.6M	-44.97M	-9.82M	-2.46M
Acquisitions	n/a	-238.22M	-30.34M	-4.72M	24.17M
Purchase of Investments	-209.03M	-254M	-330.03M	-49.86M	-41.54M
Sales Maturities Of Investments	283.9M	271.48M	76.67M	41.65M	-24.17M
Other Investing Acitivies	n/a	238.22M	30.34M	-4.72M	24.17M
Investing Cash Flow	61.13M	-13.13M	-298.34M	-22.76M	-19.83M
Debt Repayment	-10.24M	n/a	n/a	9.73M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	196.16M	37.96M	74.84M
Financial Cash Flow	-9.72M	27.16M	417.77M	47.69M	74.84M
Net Cash Flow	-36.94M	28.08M	30.43M	-16.34M	38.84M
Free Cash Flow	-102.08M	-16.55M	-133.97M	-51.09M	-18.63M